Fairfax India Holdings Corp.

  • Market Cap: N/A
  • Industry: Capital Markets
  • ISIN: CA3038971022
USD
16.50
-1.35 (-7.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Fairfax India Holdings Corp. stock-summary
stock-summary
Fairfax India Holdings Corp.
Capital Markets
Fairfax India Holdings Corp is a Canada-based investment holding company. The Company's investment objective is to achieve long-term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in India and Indian businesses or other businesses with customers, suppliers or business conducted in or dependent on India. The Company operates through investing in India segment. The Company focuses on investing in businesses that benefits India's pro-business political environment and its growing middle class and its demographic trends. The Company makes its investments through its subsidiaries, which include FIH Mauritius Investments Ltd and FIH Private Investments Ltd.
Company Coordinates stock-summary
Company Details
95 Wellington St W Suite 800 , TORONTO ON : M5J 2N7
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 6 Foreign Institutions (0.38%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Vivan Watsa
Chairman of the Board and Chairman and Chief Executive Officer of Fairfax Financial Holdings Limited
Mr. Chandran Ratnaswami
Chief Executive Officer, Director
Mr. Anthony Griffiths
Lead Independent Director
Mr. Sumit Maheshwari
Director
Mr. Gopalakrishnan Soundarajan
Director
Mr. Christopher Hodgson
Independent Director
Mr. Alan Horn
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
385 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 1,815 Million ()

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

1.98%

stock-summary
Price to Book

0.46